
Developer, Manufacturer, and Distributor of Rehabilitation Robots
VCBeat has learned exclusively that Changsha Youlong Robotics Co., Ltd. (hereinafter referred to as “Youlong Robotics”) has officially announced the completion of a strategic financing round amounting to tens of millions of yuan. This round was solely invested by Lingxin Fund, under the Changsha Urban Development Group, the flagship state-owned asset platform of the Changsha municipal government. This collaboration marks the implementation of an innovative model in China’s flexible exoskeleton robotics sector, integrating “R&D, industrial capital, and medical and cultural tourism applications,” thereby injecting strong momentum into the smart medical rehabilitation industry.

Youlong Robotics Product Collection
Yoolong Robotics originated from the Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, representing the research team with the longest tenure and strongest technical capabilities in the field of exoskeleton robotics in China. Its breakthrough innovations in flexible exoskeleton robots were awarded the First Prize for Scientific and Technological Progress in both Shenzhen City and Guangdong Province in 2023.

YouLong Flexible Exoskeleton Robot
Flexible exoskeleton robots have overcome the limitations of traditional rigid structures by simulating the human muscle contraction mechanism and integrating intelligent gait recognition technology, thereby providing precise walking assistance to patients with stroke, spinal cord injury, and other conditions. Now in its third generation, this product has achieved a technological leap from “rigid assistance” to “muscle-powered empowerment.” Youlong products have been sold across multiple provinces in China, covering numerous leading hospitals and benefiting over 10,000 patients. Furthermore, the ankle joint trainer has been exported to overseas markets including the United States, India, and Russia, earning high recognition in both domestic and international markets.
Changsha Urban Development Group’s strategic investment will focus on supporting Youlong Robotics’ upgrades in three key areas:
R&D Deepening: Further solidifying its leading position in the field of flexible exoskeleton technology. Youlong, as the sole research entity, undertook the major scientific research program “Key Technology Research on Human-Machine Integrated Exoskeletons” of Hunan Province in 2025, and simultaneously officially participated in the National Key R&D Program of the Ministry of Science and Technology titled “Research and Development of Appropriate Technologies and Systems for Wearable Exoskeletons for the Elderly and People with Disabilities.”
Production Line Expansion: Plan to build China's largest human-machine collaborative robot production base;
Scenario Development: Leveraging the high-quality cultural and tourism resources owned by Changsha Urban Development Group, we can empower Youlong’s flexible exoskeleton series products in application scenarios such as hiking assistance.
This collaboration is not merely a matter of capital alignment, but a key piece in the puzzle of the city’s holistic health industry ecosystem.

Ulong Consumer-Grade Exoskeleton - Outdoor Edition
Industry Value: Addressing the Essential Needs of an Aging SocietyAccording to the White Paper on Rehabilitation Medicine in China, the market size of rehabilitation medicine in China is projected to exceed RMB 200 billion by 2030, with intelligent rehabilitation devices achieving a compound annual growth rate (CAGR) of 35%. Youlong Robotics’ pioneering “flexible exoskeleton + cloud-based rehabilitation platform” model is driving the industry’s transformation toward home-based, lightweight, and data-driven solutions. The recent entry of state-owned capital will further accelerate the widespread adoption of its products in scenarios covered by long-term care insurance, outdoor activities such as hiking, and community elderly care centers.
Xiong Jun, Chairman of Youlong Robotics, stated: “This financing round is not only a milestone but also a statement of responsibility. Leveraging the policy and resource advantages of state-owned capital platforms, we will focus on achieving breakthroughs in technologies such as flexible sensing and deep human–machine understanding, thereby extending high-quality technological services from tertiary hospitals to community households, and fulfilling our corporate mission of ‘leveraging leading technology to create a better life for humanity.’””